The innovative fixed-dose, triple-combination clindamycin phosphate 1.2%/adapalene 0.15%/BPO 3.1% gel was efficacious and well tolerated in children, adolescents, and adults with moderate …

The purpose of this current research work describes a validated new isocratic reversed-phase high-performance liquid chromatographic (HPLC) method for simultaneous estimation of …

To improve patient compliance and lower the possibility of antibiotic resistance, a new combination gel of adapalene and clindamycin hydrochloride (adapalene–clindamycin gel) has …

Once-daily treatment with the novel fixed-dose triple-combination clindamycin phosphate 1.2%/adapalene 0.15%/BPO 3.1% gel confirmed its superior efficacy to vehicle gel over 12 …

2014年1月1日 · This paper describes a validated high-performance liquid chromatographic (HPLC) method for simultaneous estimation of clindamycin (CLI) and adapalene (ADA) in pure …

Conclusion: Adapalene 0.1%-clindamycin 1% combination gel is well tolerated and demonstrated superior efficacy over 0.1% adapalene gel monotherapy and 1% clindamycin gel monotherapy …

Abstract: The purpose of this current research work describes a validated new isocratic reversed-phase high-performance liquid chromatographic (HPLC) method for simultaneous estimation …

A novel stability-indicating RP-HPLC method was developed for the simultaneous estimation of clindamycin phosphate (hydrophilic), adapalene (hydro-phobic), phenoxyethanol, and …

2023年9月1日 · Topical clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide (BPO) 3.1% gel (IDP-126) is the first fixed-dose triple-combination in development for acne. …

2024年11月18日 · Introduction: Clindamycin phosphate (CLIN) 1.2%/adapalene (ADAP) 0.15%/benzoyl peroxide (BPO) 3.1% gel (CAB) is the only triple-combination topical treatment …